摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4R,4aS,7R,7aR,12bS)-7-(methylamino)-3-(2-methylpropyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol | 1417030-51-3

中文名称
——
中文别名
——
英文名称
(4R,4aS,7R,7aR,12bS)-7-(methylamino)-3-(2-methylpropyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol
英文别名
——
(4R,4aS,7R,7aR,12bS)-7-(methylamino)-3-(2-methylpropyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol化学式
CAS
1417030-51-3
化学式
C21H30N2O3
mdl
——
分子量
358.481
InChiKey
IUQWEWRWMUYCLN-GQHLEUQBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    26
  • 可旋转键数:
    3
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    65
  • 氢给体数:
    3
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (4R,4aS,7R,7aR,12bS)-7-(methylamino)-3-(2-methylpropyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol 、 3-(furan-3-yl)acryloyl chloride 在 三乙胺 、 sodium hydroxide 作用下, 以 二氯甲烷甲醇 为溶剂, 生成 N-[(4R,4aS,7R,7aR,12bS)-4a,9-dihydroxy-3-(2-methylpropyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide
    参考文献:
    名称:
    The effect of 17-N substituents on the activity of the opioid κ receptor in nalfurafine derivatives
    摘要:
    We have previously reported the essential structure of the opioid kappa receptor agonist nalfurafine hydrochloride (TRK-820) for binding to the kappa receptor. In the course of this study, we focused on the effect of the substituent at 17-N in nalfurafine on the binding affinity for the j receptor. The exchange of the 17-N substituent in nalfurafine from cyclopropylmethyl to fluoro-substituted alkyl groups, which are strong electron withdrawing substituents, almost completely diminished the binding affinities for the mu and delta opioid receptors, but the binding affinity for the j receptor was still maintained. As a result, nalfurafine derivatives with 17-fluoro-substituted alkyl groups showed higher selectivities for the j receptor than did nalfurafine itself. With regard to the j agonistic activities, the conversion of the 17-N substituent in nalfurafine from cyclopropylmethyl to fluoro-substituted alkyl groups led to the gradual decrease of the agonistic activities in the order corresponding to their binding affinities for the j receptor. In contrast, the derivative with the bulky 17-isobutyl group showed lower affinity and agonistic activity for the j receptor than the derivatives with the smaller functional groups. This research suggested that both the electronic property and the steric characteristics of the 17-N substituent would have a great influence on the binding property for the j receptor. (c) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.10.100
  • 作为产物:
    描述:
    6β-N-methylnaltrexamine盐酸platinum(IV) oxide 作用下, 以 为溶剂, 以100%的产率得到(4R,4aS,7R,7aR,12bS)-7-(methylamino)-3-(2-methylpropyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol
    参考文献:
    名称:
    The effect of 17-N substituents on the activity of the opioid κ receptor in nalfurafine derivatives
    摘要:
    We have previously reported the essential structure of the opioid kappa receptor agonist nalfurafine hydrochloride (TRK-820) for binding to the kappa receptor. In the course of this study, we focused on the effect of the substituent at 17-N in nalfurafine on the binding affinity for the j receptor. The exchange of the 17-N substituent in nalfurafine from cyclopropylmethyl to fluoro-substituted alkyl groups, which are strong electron withdrawing substituents, almost completely diminished the binding affinities for the mu and delta opioid receptors, but the binding affinity for the j receptor was still maintained. As a result, nalfurafine derivatives with 17-fluoro-substituted alkyl groups showed higher selectivities for the j receptor than did nalfurafine itself. With regard to the j agonistic activities, the conversion of the 17-N substituent in nalfurafine from cyclopropylmethyl to fluoro-substituted alkyl groups led to the gradual decrease of the agonistic activities in the order corresponding to their binding affinities for the j receptor. In contrast, the derivative with the bulky 17-isobutyl group showed lower affinity and agonistic activity for the j receptor than the derivatives with the smaller functional groups. This research suggested that both the electronic property and the steric characteristics of the 17-N substituent would have a great influence on the binding property for the j receptor. (c) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.10.100
点击查看最新优质反应信息

文献信息

  • MORPHINAN DERIVATIVE AND MEDICINAL USE
    申请人:TORAY INDUSTRIES, INC.
    公开号:EP0663401A1
    公开(公告)日:1995-07-19
    A morphinan derivative represented by formula (1) or a pharmacologically acceptable acid-addition salt thereof, and analgesic, diuretic, antitussive and brain cell protective agents each containing the derivative or the salt as the active ingredient. These compounds have potent analgesic, diuretic and antitussive effects as a highly selective κ-opioid agonist, and are useful as analgesic, diuretic and antitussive agents. In addition, they have a significant brain cell protective effect and are useful as a brain cell protective agent.
    由式(1)代表的吗啡南衍生物或其药理学上可接受的酸加成盐,以及含有该衍生物或盐作为活性成分的镇痛剂、利尿剂、镇咳剂和脑细胞保护剂。这些化合物作为一种高选择性κ-类阿片激动剂,具有强效的镇痛、利尿和镇咳作用,可用作镇痛、利尿和镇咳制剂。此外,它们还具有明显的脑细胞保护作用,可用作脑细胞保护剂。
  • US6177438B1
    申请人:——
    公开号:US6177438B1
    公开(公告)日:2001-01-23
查看更多